Gilead Q1 profit surges

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Gilead Sciences reported its Q1 product sales soared 16%, including $1.46B in sales of Remdesivir, the company's COVID-19 antiviral drug, but warned the sales of its hepatitis C and HIV drugs were down amid the pandemic.
Back to articles

Actual Topics

Fri, 30 Apr 2021 08:35:04 GMT

EU's Vestager plans news conference

Margrethe Vestager, the European Union's antitrust chief, is set to conduct a news conference on Friday at 11:00 GMT, where she will charge the tech giant Apple for anti-competitive practices.

Fri, 30 Apr 2021 06:00:09 GMT

Ford drops 10% amid chip shortage

Ford Motors' shares tumbled over 10% on Thursday, following the report that the global chip shortage could potentially trim its Q2 vehicle production in half.

Subscribe to "Fundamental Analysis" feed

Subscribe
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request)
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request).
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.